Lotus Pharm vs Gongwin Biopharm Holdings: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Gongwin Biopharm Holdings (6617) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Gongwin Biopharm Holdings

0%+397%-43%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYGongwin Biopharm HoldingsYoY
Oct 2026NT$2.13 billion-22.5%NT$9.3 million+397.3%
Sep 2026NT$2.77 billion+128.0%NT$2.9 million-42.6%
Aug 2026NT$2.11 billion+81.7%NT$4.6 million+7.8%
Jul 2026NT$2.49 billion+3.9%NT$4.6 million+63.5%
Jun 2026NT$3.4 billion+225.5%NT$4.5 million+70.0%
May 2026NT$2.32 billion+105.8%NT$4.4 million+68.5%
Apr 2026NT$3.09 billion+19.9%NT$3.8 million+7.6%
Mar 2026NT$4.35 billion+173.6%NT$3.1 million+11.1%
Feb 2026NT$2.24 billion+131.5%NT$2.8 million+13.4%
Jan 2026NT$2.05 billion-5.5%NT$3.2 million+36.2%
Dec 2025NT$2.44 billion+66.9%NT$3.5 million+30.5%
Nov 2025NT$1.06 billion-0.2%NT$2.6 million-12.5%
Oct 2025NT$2.75 billion+46.0%NT$1.9 million-31.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16